Skip to main content

Compare Stocks

Date Range: 

 EnvistaSmileDirectClubBIOLASEAmerican Medical TechnologiesLancer Orthodontics
Price Information
Current Price$45.25$7.98$0.69N/AN/A
52 Week RangeBuyBuyBuyN/AN/A
Overall Score1.
Analysis Score1.
Community Score2.
Dividend Score0.
Ownership Score0.
Earnings & Valuation Score1.
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/AN/A
Consensus Price Target$41.60$11.57$1.58N/AN/A
% Upside from Price Target-8.07% downside45.01% upside129.12% upsideN/AN/A
Trade Information
Market Cap$7.27 billion$3.01 billion$105.25 millionN/AN/A
Average Volume2,178,1845,951,38622,705,03721,079150
Sales & Book Value
Annual Revenue$2.75 billion$750.43 million$37.80 millionN/AN/A
Price / Sales2.644.112.74N/AN/A
Cashflow$3.65 per shareN/AN/AN/AN/A
Price / Cash12.41N/AN/AN/AN/A
Book Value$22.33 per share$1.20 per share$0.01 per shareN/AN/A
Price / Book2.036.6568.74N/AN/A
Net Income$217.60 million$-114,510,000.00$-17,850,000.00N/AN/A
Trailing P/E RatioN/AN/AN/A0.000.00
Forward P/E Ratio30.57N/AN/AN/AN/A
Net Margins-0.84%-14.44%-58.34%N/AN/A
Return on Equity (ROE)4.30%-23.62%-541.14%N/AN/A
Return on Assets (ROA)2.36%-8.98%-45.22%N/AN/A
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt-to-Equity Ratio0.49%1.49%0.23%N/AN/A
Current Ratio2.09%3.04%1.68%N/AN/A
Quick Ratio1.71%2.92%1.09%N/AN/A
Ownership Information
Institutional Ownership PercentageN/A18.91%5.52%N/AN/A
Insider Ownership Percentage0.61%66.04%2.19%18.10%24.30%
Shares Outstanding160.78 million386.94 million150.56 millionN/AN/A
Next Earnings Date7/29/2021 (Estimated)8/11/2021 (Estimated)8/12/2021 (Estimated)N/AN/A
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable
No headlines for this company have been tracked by

5/13/2021EnvistaMorgan StanleyBoost Price Target
5/12/2021EnvistaCredit Suisse GroupBoost Price Target
5/6/2021EnvistaPiper SandlerBoost Price Target
11/25/2020EnvistaBank of AmericaBoost Price Target
10/30/2020EnvistaWilliam BlairReiterated Rating
10/30/2020EnvistaJPMorgan Chase & Co.Boost Price Target
5/11/2021SmileDirectClubStephensLower Price Target
3/5/2021SmileDirectClubThe Goldman Sachs GroupReiterated Rating
3/5/2021SmileDirectClubStifel NicolausReiterated Rating
12/8/2020SmileDirectClubWolfe ResearchUpgrade
8/18/2020SmileDirectClubGuggenheimReiterated Rating
5/20/2020SmileDirectClubUBS GroupLower Price Target
5/14/2020SmileDirectClubJefferies Financial GroupReiterated Rating
2/26/2020SmileDirectClubLoop CapitalReiterated Rating
5/14/2021BIOLASEMaxim GroupReiterated Rating
3/8/2021BIOLASEColliers SecuritiesReiterated Rating
8/12/2019BIOLASEAscendiant Capital MarketsSet Price Target
6/19/2019BIOLASEBenchmarkInitiated Coverage
4/30/2019BIOLASEDougherty & CoReiterated Rating
3/7/2019BIOLASESingular ResearchReiterated Rating
(Data available from 5/17/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.